Safety concerns with meperidine

Journal of Perianesthesia Nursing

Volumn 17, Issue 2, 2002, Pages 123-125

  Golembiewski, Julie ^a,b,c  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; BUSPIRONE; CLOMIPRAMINE; DESIPRAMINE; DEXTROMETHORPHAN; DOXEPIN; FENFLURAMINE; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; GUAIFENESIN; IMIPRAMINE; ISOCARBOXAZID; LITHIUM CARBONATE; LYSERGIDE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NORPETHIDINE; NORTRIPTYLINE; OPIATE; PAROXETINE; PETHIDINE; PHENELZINE; PHENOTHIAZINE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; TRANYLCYPROMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE; NARCOTIC ANALGESIC AGENT;

ATAXIA; AUTONOMIC NEUROPATHY; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; DIAPHORESIS; DIARRHEA; DISORIENTATION; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG METABOLISM; DRUG SAFETY; FEVER; HUMAN; HYPERREFLEXIA; KIDNEY FAILURE; MYOCLONUS; NEUROMUSCULAR DISEASE; PAIN; RESTLESSNESS; RIGOR; SEROTONIN SYNDROME; SHIVERING; SHORT SURVEY; SIDE EFFECT; TACHYCARDIA; TONIC CLONIC SEIZURE; TREATMENT WITHDRAWAL; TREMOR; URINE PH; ARTICLE;

ANALGESICS, OPIOID; HUMANS; MEPERIDINE; PAIN;

EID: 0036546960     PISSN: 10899472     EISSN: None     Source Type: Journal    
DOI: 10.1053/jpan.2002.31661     Document Type: Article

References (13)

1. Hermes ER, Hare BD: Meperidine neurotoxicity: Three case reports and a review of the literature. Journal of Pharmaceutical Care in Pain & Symptom Control 1:5-20, 1993
2. Shimomura SK, Harris S: Pain management of patients with sickle cell anemia. Hosp Pharm 14:332-336, 1979
3. Kaiko RF, Foley KM, Grabinski PY, et al: Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol 13:180-185, 1983
4. Mauro VF, Bonfiglio MF, Spunt AL: Meperidine-induced seizures in a patient without renal dysfunction or sickle cell anemia. Clin Pharmacol 5:837-839, 1986
5. Acute Pain Management Panel: Acute Pain Management; Operative or Medical Procedures and Trauma. Clinical Practice Guideline. AHCPR Publication No. 92-0032. Rockville, MD, Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services, 1992
6. Pain Management Panel: Management of Cancer Pain: Clinical Practice Guideline No. 9. AHCPR Publication No. 94-0592. Rockville, MD, Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services, 1994
7. American Pain Society: Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain. Glenview, IL, 1999, p 31
8. Mills KC: Serotonin syndrome: A clinical update. Critical Care Clinics 13:763-783, 1997
9. Mason PJ, Morris V, Balcezak T: Serotonin syndrome: Presentation of 2 cases and review of the literature. Medicine 79:201-209, 2000
10. Sporer KA: The serotonin syndrome - Implicated drugs, pathophysiology and management. Drug Safety 13:94-104, 1995
11. Lee F, Cundiff D: Meperidine vs. morphine in pancreatitis and cholecystitis. Arch Intern Med 158:2399, 1998
12. Radnay PA, Duncalf D, Novakovic M, et al: Common bile duct pressure changes after fentanyl, morphine, meperidine, butorphanol, and naloxone. Anesth Analg 63:441-444, 1984
13. Radnay PA, Boradman E, Mankikar D: The effects of equi-analgesic doses of fentanyl, morphine and pentazocine on common bile duct pressure. Anaesthetist 29:26-29, 1980